Inbiobank is a non profit-making bank of stem and primary cells the function of which is to produce and characterise such cells for their use in applied research, both basic and clinical.
Inbiobank’s installations have technologically pioneering, state-of-the-art equipment. Its cell production plant has ISO 9001- 2000 quality certification and it works in and operates with GMP (Good Manufacturing Practices) conditions, thus guaranteeing the clinical quality of the cells produced. Moreover, these installations have been authorised as pharmaceutical laboratories (Nº 4206 E) by the Spanish Medication Agency to carry out clinical trials (PEI 05-057) using somatic cell therapy, only the second throughout Spain with such authorisation.
About adult stem cells
Adult stem cells are responsible for cellular and tissue regeneration and are located in various tissues of the body. Generally these are extracted from easily-accessible tissues with high capacity for renovation, such as bone marrow, skin, intestine and fatty tissue.
Thanks to their potential therapeutic and regenerative activity, adult stem cells provide multiple possibilities for the treatment of many pathologies. Moreover, given their adult origin, they are free of the legal and ethical problems associated with stem cells originating from other sources.
Basic research at Inbiomed
Currently, Inbiomed is working on three main lines of basic research, all based on the study of adult stem cells of human origin and that come from a number of different tissues:
· bone marrow, umbilical cord and adipose tissue stem cells
· skin stem cells
· neuronal stem cells
Within these lines of research, Inbiomed is studying the mechanisms, both genetic and biochemical, that intervene in the multiplication and differentiation of these cells in the various body tissues as well as in their biological function. The quest is also to find ways of reconstituting in vitro the environment in which these adult stem cells multiply and differentiate.
Clinical research at Inbiomed
The Inbiomed Foundation is participating, together with the Spanish Consortium for Epidermolisis Bullosa in clinical trials (PEI 05- 057) the aim of which is to test the efficacy and safety of a new treatment for Epidermolisis Bullosa, and based on the use of engineered chimeric bilaminar skin (produced artificially in the pharmaceutical laboratory), and compare it with a current commercial treatment.
Irati Kortabitarte | alfa
Cryo-electron microscopy achieves unprecedented resolution using new computational methods
24.03.2017 | DOE/Lawrence Berkeley National Laboratory
How cheetahs stay fit and healthy
24.03.2017 | Forschungsverbund Berlin e.V.
Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.
The results will be published on March 22 in the journal „Astronomy & Astrophysics“.
Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...
Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.
Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...
In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...
20.03.2017 | Event News
14.03.2017 | Event News
07.03.2017 | Event News
24.03.2017 | Materials Sciences
24.03.2017 | Physics and Astronomy
24.03.2017 | Physics and Astronomy